Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares, at a price of approximately HK$72.88 per share.
After the increase, the latest number of shares held is 15.096 million shares, and the latest shareholding ratio is 5.05%.
According to the latest data from the Hong Kong Stock Exchange, on July 30, Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares at a price of HKD 72.8753 per share, for a total amount of approximately HKD 14.8301 million. After the increase, the total number of shares held is 15.096 million, with the latest shareholding ratio at 5.05%.
Related Articles
Changfeng Pharmaceutical (02652) has completed the placement of 21.477 million new H shares, raising approximately HK$295 million.
PICC P&C (02328): Lu Chen's qualifications for the position of Executive Director have been approved.
Zhongzheng International (00943) plans to sell 100% of PT Karya Dasar Bumi's equity and transfer sales loans for 1.2 million USD.
Changfeng Pharmaceutical (02652) has completed the placement of 21.477 million new H shares, raising approximately HK$295 million.
PICC P&C (02328): Lu Chen's qualifications for the position of Executive Director have been approved.
Zhongzheng International (00943) plans to sell 100% of PT Karya Dasar Bumi's equity and transfer sales loans for 1.2 million USD.
RECOMMEND
